$0.155

0.005 (3.13%)

Are you using our Portfolio Manager?

Track, improve and optimise your portfolio - for free.

Get Started

General Information

Acrux Limited
ACR
http://www.acrux.com.au
Pharmaceuticals
27
167

Current Price Data+

Current Price $0.155
Open $0.160
High $0.160
Low $0.150
Last Close $0.160
Volume 548182
Price Movement $0.01 ( 3.13% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

Company Overview

Business Description

Acrux Limited (ACR) is an Australian drug delivery company, who is developing and commercialising pharmaceutical products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including AXIRON, Evamist and Recuvyra.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2019 F -8,878.8 -5.3 -0.7% -3.2 0.0 0.0% 100.0%
2018 F -8,938.7 -5.4 -185.6% -3.2 0.0 0.0% 100.0%
2017 A 10,437.0 6.3 -19.6% 5.9 0.0 0.0% 100.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2017 A 2018 F 2019 F 2017 A 2018 F 2019 F 2017 A 2018 F 2019 F
Acrux Limited (ACR) $28M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mayne Pharma Group (MYX) $1,111M 0.0476 0.0501 0.0838 11.0015 10.4769 9.6667 0.00% 0.00% 0.00%
Starpharma (SPL) $388M 0.0000 0.0000 4.4545 0.0000 106.0606 19.4444 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 3.00 0.00 0.61 0.00
Market 1.12 16.60 1.48 1.73
Sector 0.82 12.00 3.61 1.66

Directors

Name Position Start Date
Mr Michael Kotsanis Chief Executive Officer, Managing Director 3 Nov 2014
Mr Ross Dobinson Non-Executive Chairman 19 Mar 1998
Dr Geoffrey E.D Brooke Non-Executive Director 1 Jun 2016
Dr Timothy Oldham Non-Executive Director 1 Oct 2013
Dr Simon Green Non-Executive Director 1 Jun 2016

Management

Name Position
Tim Bateman Chief Financial Officer,Company Secretary
N Webster Commercial Director
C O'Sullivan Portfolio Director
F Colagrande Product Development and Technical Affairs Director

Substantial Shareholders

Holding Name
24,010,724 (14.42%) Allan Gray Australia Pty Ltd

Calendar of Events

Date Event
21 August 2018 Report (Prelim)
16 February 2018 Report (Interim)
06 October 2017 Report (Annual)

© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.